welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
-
Genetic testing for hereditary cancer syndromesGenetic testing looks for specific inher...
-
Diagnostic Values of Dual Focus Narrow Band Imaging and Probe-Based Confocal Laser Endomicroscopy in FAP-Related Duo...BACKGROUND AND STUDY AIMS : Familial ade...
-
Diagnosis, Surveillance, and Treatment Strategies For Familial Adenomatous Polyposis: Rationale and UpdateFamilial adenomatous polyposis is charac...
-
Genotype and Phenotype of Patients with Both Familial Adenomatous Polyposis and Thyroid CarcinomaThe incidence of thyroid carcinoma in fa...
-
Patient Information: Colon and Rectal Cancer Screening (Beyond the Basics)Colorectal cancer develops in the large ...
-
Familial Syndromic Papillary Thyroid Carcinoma Report of Two CasesAIM : to describe two cases of familial ...
-
Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard EndoscopyThe purpose of this study is to establis...